1-3 of 3
Mark J. Cantwell
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Ad-ISF35-Transduced Autologous Cells In Combination with Fludarabine, Cyclophosphamide, Rituximab (FCR) Induces Complete and Partial Responses In a Phase 1b Study for Patients with Fludarabine-Refractory and/or Del(17p)/p53-Defective Chronic Lymphocytic Leukemia (CLL)

Free
Januario E. Castro, M.D., Lee Schwartzberg, MD, FACP, Javier Pinilla-Ibarz, MD, PhD, Johanna Melo-Cardenas, B.Sc, Juan S. Barajas-Gamboa, M.D., Mark J. Cantwell, PhD, Thomas J. Kipps, M.D., Ph.D
Journal: Blood
Blood (2011) 118 (21): 168.
https://doi.org/10.1182/blood.V118.21.168.168
Published: 2011
Journal Articles

Ad-ISF35- Transduced Autologous Cells Promote In Vitro and In Vivo Chemosensitization to FCR and Durable Complete Responses In Patients with Del(17p)/P53 Defective Chronic Lymphocytic Leukemia.

Free
Januario E Castro, M.D, Johanna Melo-Cardenas, B.Sc, Juan Sebastian Barajas-Gamboa, M.D, Mauricio Urquiza, PhD, Mark J. Cantwell, PhD, Thomas J. Kipps, MD, PhD
Journal: Blood
Blood (2010) 116 (21): 1472.
https://doi.org/10.1182/blood.V116.21.1472.1472
Published: 2010
Journal Articles

CD40-ligand (CD154) gene therapy for chronic lymphocytic leukemia

Free
Clinical Trials & Observations
William G. Wierda, Mark J. Cantwell, Sandra J. Woods, Laura Z. Rassenti, Charles E. Prussak, Thomas J. Kipps
Journal: Blood
Blood (2000) 96 (9): 2917–2924.
https://doi.org/10.1182/blood.V96.9.2917
Published: 2000